168 related articles for article (PubMed ID: 1364913)
1. [Hormone treatment of breast cancer].
Gröhn P
Duodecim; 1991; 107(8):603-10. PubMed ID: 1364913
[No Abstract] [Full Text] [Related]
2. Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy.
Montemurro F; Aglietta M
Endocr Relat Cancer; 2009 Dec; 16(4):1091-102. PubMed ID: 19726539
[TBL] [Abstract][Full Text] [Related]
3. Problems and solutions in the evaluation of hormone receptors in breast cancer.
Allred DC
J Clin Oncol; 2008 May; 26(15):2433-5. PubMed ID: 18487563
[No Abstract] [Full Text] [Related]
4. [Anti-hormonal therapy in breast cancer].
Ecker-Schlipf B
Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152
[No Abstract] [Full Text] [Related]
5. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
[No Abstract] [Full Text] [Related]
6. Biochemical basis of breast cancer treatment by androgens and progestins.
Rochefort H
Prog Clin Biol Res; 1984; 142():79-95. PubMed ID: 6538685
[No Abstract] [Full Text] [Related]
7. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.
Mehta RS
J Clin Oncol; 2008 Jul; 26(19):3286-8; author reply 3288. PubMed ID: 18591566
[No Abstract] [Full Text] [Related]
8. [Effects and mechanism of action of antiestrogens in breast cancer].
Borgna JL; Rochefort H
Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
[TBL] [Abstract][Full Text] [Related]
9. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R
Cancer Res; 1978 Nov; 38(11 Pt 2):4299-304. PubMed ID: 698970
[No Abstract] [Full Text] [Related]
10. Changing concepts of hormone receptor-positive advanced breast cancer therapy.
Chlebowski RT
Clin Breast Cancer; 2013 Jun; 13(3):159-66. PubMed ID: 23228361
[No Abstract] [Full Text] [Related]
11. Adjuvant chemotherapy for early-stage breast cancer.
McArthur HL; Hudis CA
Hematol Oncol Clin North Am; 2007 Apr; 21(2):207-22. PubMed ID: 17512445
[TBL] [Abstract][Full Text] [Related]
12. HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
Rydén L; Landberg G; Stål O; Nordenskjöld B; Fernö M; Bendahl PO
Breast Cancer Res Treat; 2008 May; 109(2):351-7. PubMed ID: 17636399
[TBL] [Abstract][Full Text] [Related]
13. Droloxifene--a novel antiestrogen in endocrine dependent human tumors xenotransplanted into nude mice.
Stelzer P; Staab HJ; Kömpf J
Strahlenther Onkol; 1989 Jul; 165(7):559-60. PubMed ID: 2749496
[No Abstract] [Full Text] [Related]
14. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
15. Solving the puzzle of hormone-dependent breast cancer.
Santen RJ
Trans Am Clin Climatol Assoc; 1992; 103():164-75. PubMed ID: 1413376
[No Abstract] [Full Text] [Related]
16. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
17. [Hormone dependence and the basis of hormone therapy in breast cancer].
Martin PM
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):183-99. PubMed ID: 209076
[No Abstract] [Full Text] [Related]
18. Relation of tumor content of estrogen and progesterone receptors with response of patient to endocrine therapy.
Brooks SC; Saunders DE; Singhakowinta A; Vaitkevicius VK
Cancer; 1980 Dec; 46(12 Suppl):2775-8. PubMed ID: 7448719
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
Thomas S; Munster PN
Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986
[TBL] [Abstract][Full Text] [Related]
20. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
